| Autor: |
Nadkarni A; Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, Room 372, Wilson Pharmacy Building, University of Georgia, Athens, GA 30602-2352, USA., Kelley LL, Momany C |
| Jazyk: |
angličtina |
| Zdroj: |
Protein expression and purification [Protein Expr Purif] 2007 Mar; Vol. 52 (1), pp. 219-29. Date of Electronic Publication: 2006 Oct 26. |
| DOI: |
10.1016/j.pep.2006.10.011 |
| Abstrakt: |
A mutagenized mouse recombinant antibody fragment (rFab) that recognized HIV capsid protein was isolated from Escherichia coli at a level of 12 mg per liter of culture using standard shake flask methods. This is one of the highest yields of a modified antibody fragment obtained using non-fermentor-based methods. Recombinant Fab was isolated directly from the culture medium, which lacked complex materials such as tryptone and yeast extract. Fab isolated from the periplasm was not as homogeneous as that isolated directly from the culture medium. Optimization of the culture medium using recently developed media, the use of E. coli cell lines that contained rare tRNA codons, and mutagenesis of the Fab to improve the stability of the Fab were important factors in producing high-levels of the Fab. An isolation protocol easily adaptable to automation using a thiophilic-sepharose column followed by metal-chelate chromatography and the introduction of a non-traditional metal binding site for metal-chelate purification that bypasses the conventional hexahistidine tag cleavage step (to prevent the purification tag from interfering with crystallization) are additional features of this approach to produce a highly homogenous preparation of rFab. The resulting rFab binds to its antigen, p24, equivalent in character to the monoclonal from which the rFab was originally derived. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect